BMAC

Bone marrow aspirate concentrate (BMAC) is a next-generation orthobiologic stem cell therapy that uses the body’s own cellular components to support deep tissue regeneration and repair. BMAC contains a potent mix of mesenchymal stem cells, hematopoietic progenitor cells, growth factors, cytokines, and extracellular vesicles, all of which play key roles in regulating inflammation, promoting angiogenesis, and stimulating tissue remodeling. Compared to PRP, BMAC offers a broader and more potent regenerative profile — making it especially valuable in advanced musculoskeletal degeneration, tendon and cartilage injuries, and non-healing soft tissue conditions.

At the Performance Medicine Institute, BMAC is obtained through a minimally invasive bone marrow aspiration procedure — typically from the posterior iliac crest under local anesthesia — and processed using advanced centrifugation techniques to isolate the highest concentration of regenerative components. We then deliver BMAC directly to the target tissue (e.g., joint, tendon, ligament, fascia) using ultrasound or fluoroscopic guidance, ensuring maximum therapeutic precision.

BMAC is particularly useful in cases where PRP alone may be insufficient, such as moderate-to-severe osteoarthritis, labral tears, rotator cuff injuries, avascular necrosis, and chronic tendinopathies. It can also be used in post-surgical recovery to accelerate healing and improve tissue integration. By stimulating both cellular repair and structural regeneration, BMAC represents a powerful, surgery-sparing tool for patients seeking long-term resolution of chronic orthopedic conditions.